Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Braz. j. infect. dis ; 13(3): 210-217, June 2009. ilus, tab, graf
Artículo en Inglés | LILACS | ID: lil-538522

RESUMEN

Intestinal barrier function and serum concentrations of rifampin, isoniazid and pyrazinamide were studied in healthy controls and patients with active pulmonary tuberculosis. A case-control study of 29 controls and 30 cases attending at the Health Center, July, 2004 to December, 2005 was conducted. The body mass index was significantly reduced in cases compared to controls (p < 0.001). The intestinal paracellular transport of lactulose was significantly (p = 0.019) reduced in cases compared to controls. The transcellular transport of mannitol and the lactulose:mannitol ratio were not significantly (p = 0.0698) reduced in cases compared to controls. Low serum concentrations of rifampin, isoniazid and pyrazinamide were observed in 81 percent (48/59), 92 percent (54/59) and 28 percent (12/59), respectively, in all individuals. The results demonstrated a marked decrease on intestinal paracellular transport in patients with active pulmonary tuberculosis and reduced serum concentrations of rifampin and isoniazid in both groups.


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Antituberculosos/farmacocinética , Absorción Intestinal/fisiología , Tuberculosis Pulmonar/metabolismo , Antituberculosos/sangre , Antituberculosos/uso terapéutico , Estudios de Casos y Controles , Isoniazida/sangre , Isoniazida/farmacocinética , Isoniazida/uso terapéutico , Pirazinamida/sangre , Pirazinamida/farmacocinética , Pirazinamida/uso terapéutico , Rifampin/sangre , Rifampin/farmacocinética , Rifampin/uso terapéutico , Factores de Tiempo , Tuberculosis Pulmonar/sangre , Tuberculosis Pulmonar/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA